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Although several reports have characterized the hematopoietic stem cell (HSC) transcriptome, the roles of HSC-specific
genes in hematopoiesis remain elusive. To identify candidate regulators of HSC fate decisions, we compared the
transcriptome of human umbilical cord blood and bone marrow CD34
þCD33
 CD38
 Rho
loc-kit
þ cells, enriched for
hematopoietic stem/progenitor cells with CD34
þCD33
 CD38
 Rho
hi cells, enriched in committed progenitors. We
identified 277 differentially expressed transcripts conserved in these ontogenically distinct cell sources. We next
performed a morpholino antisense oligonucleotide (MO)-based functional screen in zebrafish to determine the
hematopoietic function of 61 genes that had no previously known function in HSC biology and for which a likely
zebrafish ortholog could be identified. MO knock down of 14/61 (23%) of the differentially expressed transcripts
resulted in hematopoietic defects in developing zebrafish embryos, as demonstrated by altered levels of circulating
blood cells at 30 and 48 h postfertilization and subsequently confirmed by quantitative RT-PCR for erythroid-specific
hbae1 and myeloid-specific lcp1 transcripts. Recapitulating the knockdown phenotype using a second MO of
independent sequence, absence of the phenotype using a mismatched MO sequence, and rescue of the phenotype by
cDNA-based overexpression of the targeted transcript for zebrafish spry4 confirmed the specificity of MO targeting in
this system. Further characterization of the spry4-deficient zebrafish embryos demonstrated that hematopoietic
defects were not due to more widespread defects in the mesodermal development, and therefore represented primary
defects in HSC specification, proliferation, and/or differentiation. Overall, this high-throughput screen for the
functional validation of differentially expressed genes using a zebrafish model of hematopoiesis represents a major
step toward obtaining meaningful information from global gene profiling of HSCs.
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Introduction
Hematopoiesis is the process by which hematopoietic stem
cells (HSCs) give rise to all hematopoietic lineages during the
lifetime of an individual. To sustain lifelong hematopoiesis,
HSCs must self-renew to maintain or expand the HSC pool
[1], and they must differentiate to form committed hema-
topoietic progenitor cells (HPCs) that progressively lose self-
renewal potential and become increasingly restricted in their
lineage potential. A combination of extrinsic and intrinsic
signals are thought to converge to regulate HSC differ-
entiation versus self-renewal decisions, but the molecular
mechanisms that regulate these processes are poorly under-
stood [2].
A multitude of cytokines have been cloned that affect HSCs
and HPCs; however, to date none of these, alone or in
combination, can induce the symmetrical, self-renewing HSC
cell division in vitro that is required for HSC expansion.
Recently, several novel regulators of HSC fate decisions have
been identiﬁed. For instance, overexpression of Hoxb4 results
in expansion of murine and human HSCs with an increased
competitive repopulation potential [3–5]; novel extrinsic
regulators implicated in self-renewal of HSCs include Notch
[6], Wnt [7,8], and the morphogens, SHH (sonic hedgehog) [9]
and BMP4 (bone morphogenetic protein 4) [9]. While the
discovery of these novel regulators provides credence to the
hypothesis that extrinsic and intrinsic signals can inﬂuence
HSC fate, a more global gene and/or protein expression
analysis of human HSC should provide additional insight into
pathways that support HSC self-renewal.
Our current understanding of the expressed gene proﬁle of
HSCs comes primarily from murine HSCs that can be
puriﬁed to near homogeneity [10–14]. The inability to purify
human HSCs to similar degrees of homogeneity makes study
of the transcriptome of human HSCs more difﬁcult. Human
HSCs and HPCs are CD34 positive, while cells that engraft in
severe combined immunodeﬁciency (SCID) mice are enriched
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þLineage(Lin)
 CD38
  fraction [15]. As fewer than
1/500 CD34
þLin
 CD38
  cells can repopulate SCID mice [15],
the expressed gene proﬁle of CD34
þLin
 CD38
  cells is likely
only partially enriched for HSC-speciﬁc genes [12,16]. We
previously demonstrated that the rhodamine (Rho) 123
  and
c-kit
þ subpopulation of CD34
þLin
 CD38
  cells (Rho
lo) cells
are highly enriched for primitive HPCs with myeloid–
lymphoid initiating cell (ML–IC) capacity relative to
CD34
þCD38
 CD33
 Rho
hi (Rho
hi) cells [17]. Thus, such selec-
tion separates CD34
þLin
 CD38
  cells into HSC-enriched and
HSC-depleted populations.
We hypothesized that comparison of the transcriptome of
Rho
lo and Rho
hi cells from umbilical cord blood (UCB) and
bone marrow (BM) should identify conserved genes and gene
pathways that deﬁne the human HSC. Because of the inherent
limitations of using gene expression data to infer biological
gene function, we also assessed the hematopoietic role of
these genes in a high-throughput in vivo functional genomics
screen in the zebraﬁsh. Using this strategy we have not only
identiﬁed a series of genes that may represent novel
regulators of human HSC fate decisions, but this work also
represents, to our knowledge, the ﬁrst example of a func-
tional genetic screening strategy that is a critical step toward
obtaining biologically relevant functional data from global
gene-proﬁling studies.
Results/Discussion
ML–ICs Are Highly Enriched in Rho
lo Compared to Rho
hi
Cells
The study of human HSCs has been limited since the
CD34
þLin
 CD38
  fraction of hematopoietic cells, commonly
used as an HSC-enriched population, contains fewer than
0.2% SCID-repopulating cells [15], suggesting considerable
heterogeneity. We have shown that ML–IC s, single hema-
topoietic cells that can generate several daughter cells
capable of reinitiating long-term myeloid and long-term
lymphoid cultures, are highly enriched by selecting the Rho
lo
fraction of CD34
þLin
 CD38
  cells. While the Rho
lo popula-
tion still only contains 15%–25% ML–ICs and therefore
remains heterogeneous, the enrichment factor is 5- to 10-fold
greater than CD34
þLin
 CD38
  cells [17]. Similar to our
previous studies, the ML–IC frequency was greater than or
equal to 10-fold higher in UCB Rho
lo compared to Rho
hi cells
(Figure S1).
Genes Differentially Expressed between Rho
lo and Rho
hi
Cells from Both UCB and BM
We hypothesized that comparing genes differentially
expressed between Rho
lo and Rho
hi cells from ontogenically
distinct sources would identify conserved genes and gene
pathways that govern self-renewal and differentiation of
human HSCs. The experimental design used is illustrated in
Figure 1. We deﬁned differentially expressed probe sets as
those with p , 0.05, using a paired Student’s t-test. By taking
into account the variability present in primary cell popula-
tions, this provides a more accurate analysis of differential
gene expression compared with the commonly used fold
change cutoff.
We identiﬁed 2,707 and 4,667 probe sets differentially
expressed between Rho
lo and Rho
hi cells from UCB and BM,
respectively (see Tables S1 and S2). The ﬁdelity of our
microarray results was conﬁrmed using quantitative RT-PCR
(Q-RT-PCR) (see Figure S2). We focused our further analysis
on 277 unique transcripts, represented by 304 probe sets that
were differentially expressed between Rho
lo and Rho
hi cells
from both UCB and BM with a fold change greater than 1.5 in
either UCB or BM (Table S3).
Among the conserved genes enriched in Rho
lo cells, many
have been implicated in early hematopoiesis, including
CDKN1A, a cell cycle regulator required for maintenance of
murine HSCs [18], and ABCB1, the ABC-transporter family
member responsible for the Rho
lo phenotype [17]. Several
transcription factors (TFs) known to play a role in early
hematopoiesis or leukemogenesis were also identiﬁed, in-
cluding HLF, involved in leukemogenic chromosomal trans-
locations [19] and EVI1, a TF associated with myeloid
leukemias [20]. Other TFs without a known role in hema-
topoiesis were also more highly expressed in Rho
lo cells,
including HMGA2, a high-mobility group gene, and the zinc
ﬁnger TFs ZNF165, ZNF331, and KLF5. All Rho
lo-enriched
genes are listed in Table S3. As demonstrated in previous
HSC gene-proﬁling studies [12–14], more than 40% of genes
enriched in Rho
lo cells lack a functional annotation, are
hypothetical proteins, or are expressed sequence tags, and
thus may represent currently uncharacterized regulators of
HSC fate decisions (Figure S3).
Figure 1. Fluorescence-Activated Cell Sorting and Gene Expression
Analysis
UCB or adult BM CD34
þCD33
 CD38
 Rho
loc-kit
þ (Rho
lo;s t e mc e l l
enriched) and CD34
þCD33
 CD38
 Rho
hi (Rho
hi; stem cell depleted) cell
populations were sorted for subsequent global gene expression
profiling. Total RNA was isolated from Rho
lo and Rho
hi cell populations
prior to linear amplification and labeling for hybridization to the
Affymetrix HG-U133 GeneChip set (approximately 45,000 probe sets)
and subsequent data analysis.
DOI: 10.1371/journal.pbio.0030254.g001
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Functional Analysis of HSC Gene ExpressionSome genes with well-established roles in HSC self-renewal
and early differentiation are not present in the Rho
lo
enriched gene list. However, most of these were differentially
expressed in both datasets, but differences did not reach
statistical signiﬁcance. For instance, LMO2 [21] and GATA2
[22], known to be involved in HSC development and self-
renewal, were expressed signiﬁcantly higher in BM Rho
lo than
in Rho
hi cells. Although similar trends were seen in UCB
Rho
lo cells, these differences were not statistically signiﬁcant
(Table S4). Conversely, HOXB4 [4] expression was signiﬁcantly
higher in UCB Rho
lo than in Rho
hi cells, but this difference
was not statistically signiﬁcant in BM. Although our stringent
criteria for differential expression likely contribute to the
omission of some genes that might be differentially ex-
pressed, another explanation might be that expression of
these genes is maintained when cells differentiate from a
Rho
lo to a Rho
hi stage. The latter is consistent with the fact
that most known HSC-associated genes were expressed at
much higher levels than the normalized average microarray
expression level in Rho
lo and in Rho
hi cells from both UCB
and BM (Table S4).
Conserved genes enriched in the Rho
hi cells included LEF1,
an effector of Wnt signaling expressed in pre-B and T cells
[23], and NOTCH2, involved in hematopoietic differentiation
cell-fate decision [24]. Several TFs known to play a role in
hematopoietic cell differentiation were more highly ex-
pressed in Rho
hi compared to Rho
lo cells, including HELLS
and MAFB [25,26]. Additional TFs with no known role in
hematopoietic development were also enriched in Rho
hi cells,
such as the zinc ﬁnger homeobox gene, ZFHX1B and the
polycomb genes, EZH2 and SUZ12, the latter required for
germ cell development [27]. Globin (Hb) gene family members
were also more highly expressed in UCB and BM Rho
hi than
in Rho
lo cells. Consistent with the ontogenic expression
patterns of fetal versus adult Hb genes, Hbc genes were more
highly expressed in perinatal UCB Rho
hi cells, while Hbb
genes were more highly expressed in adult BM Rho
hi cells.
Additional genes enriched in Rho
hi cells are listed in Table
S3.
Because of functional redundancy among gene families, we
examined the data for common differentially expressed gene
family members. The Id family of transcriptional repressors
[28] was enriched in the Rho
lo fraction, but was represented
by different family members in UCB (ID4) and BM (ID1, ID2,
and ID3). Similarly, various H1 and H2 histone genes were
enriched in the Rho
lo fraction in both datasets, but were
represented by distinct family members.
We also evaluated whether common differentially ex-
pressed genes were concentrated on speciﬁc chromosomes.
We found that genes were not only concentrated on certain
chromosomes, but at speciﬁc g-band addresses. Of the genes
enriched in Rho
lo cells, 9% reside at 6p21, a region involved
in recurrent chromosomal translocations in myeloid [29] and
lymphoid [30] leukemias, and home to the PIM1 oncogene
[31]. Six members of the H2B and one member of the H1
histone family, as well as CDKN1A, more highly expressed in
Rho
lo than Rho
hi cells, reside at 6p21. The remaining Rho
lo-
enriched genes at 6p21 consist of six class II major
histocompatibility complex (MHC) family members and a
putative testis-speciﬁc zinc ﬁnger TF, ZNF165. H1 and H2
histone gene family members [11,13], class II MHC antigens
[12,13], and CDKN1A [13] were also found among the genes
identiﬁed in studies characterizing the transcriptome of
murine HSC. The differential expression of such a large
number of genes located at this chromosomal address
suggests that, like CDKN1A, other genes located at 6p21 with
as yet unknown hematopoietic function may play a role in
HSC proliferation or differentiation.
We also compared the genes expressed more highly in
Rho
lo versus Rho
hi cells with published gene expression data.
Figure 2. Functional Genomics Screen in Zebrafish
The hematopoietic function of differentially expressed candidate genes
was determined by injecting MOs into one- to two-cell embryos from
gata1:DsRed Tg zebrafish to disrupt gene expression. Injected embryos
were scored at 30–48 hpf for the presence of DsRed
þ blood cells by
fluorescence microscopy. Subsequently, MO-targeted embryos with
gross hematopoietic defects were analyzed for the expression of the
early hematopoietic markers gata1 and scl by whole-mount in situ
hybridization, and the late hematopoietic markers hbae1 and lcp1 by Q-
RT-PCR.
DOI: 10.1371/journal.pbio.0030254.g002
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Functional Analysis of HSC Gene ExpressionComparison with the study by Ivanova et al. [12] that
compared human CD34
þLin
 CD38
  with CD34
þLin
 CD38
þ
cells, yielded only seven genes in common: ARMCX2, CRYGD,
HLF, KIAA1102, RBPMS, SLCO3A1, and SSBP2. The lack of
overlap may not be that surprising as Rho
lo and Rho
hi cells
are subpopulations of the CD34
þLin
 CD38
  population used
by Ivanova et al. Comparison of genes expressed more highly
in Rho
lo versus Rho
hi cells with genes expressed more highly in
murine side population/KLS/CD34
  compared to total BM
cells published by Ramalho-Santos et al. [13] identiﬁed 16
likely orthologs and 38 common gene family members (Table
S5), suggesting that HSC-speciﬁc genes are conserved across
species.
In vivo functional genomics screen in zebraﬁsh. Because
gene proﬁling per se does not prove functional importance,
we developed an in vivo functional genomics screen in
zebraﬁsh (Figure 2). The zebraﬁsh, Danio rerio, is an ideal
organism for high-throughput genetic screens [32] as organo-
genesis is highly conserved from zebraﬁsh to man [33]. There
is abundant evidence that hematopoiesis in zebraﬁsh occurs
via a highly conserved genetic program. As in mammals,
hematopoiesis in zebraﬁsh occurs via speciﬁcation of
mesoderm to a hemangioblast stage that subsequently
commits to either HSC or angioblasts [34], and genes and
signals involved in speciﬁcation (BMP signaling) and commit-
ment (vascular endothelial growth factor signaling; ﬂk1, also
known as kdr; lmo2; scl, also known as tal1; gata2; gata1) are
conserved from ﬁsh to man [35]. This high degree of
homology in the genetic control of zebraﬁsh and human
hematopoietic development makes genetic screens in zebra-
ﬁsh a powerful tool to elucidate the role of genes in
hematopoiesis. Additionally, rapid reverse genetic screens
can be accomplished using morpholino antisense oligonu-
cleotides (MOs) to knock down gene expression in the
developing zebraﬁsh embryo [36].
From the 277 unique transcripts that were differentially
expressed between Rho
lo and Rho
hi cells of both UCB and BM
(Table S3), we eliminated genes with known function in
hematopoiesis, MHC genes, histones, and genes that are
known to play a role in glucose and protein metabolism and
RNA and DNA synthesis, resulting in a ﬁnal list of 158 genes.
Of these, we identiﬁed a putative zebraﬁsh ortholog for 86,
and designed MOs against 61 (Table S6). The 61 MOs were
injected in one- to two-cell zebraﬁsh embryos and assayed for
effects on blood development. Initial dosing studies identiﬁed
16/61 MOs that reduce blood cell production without
confounding toxicities (Table 1). The 16 MOs induced a
blood defect in more than 70% of embryos in two or more
independent injections. Blood defects identiﬁed by ga-
ta1:DsRed transgenic (Tg) ﬂuorescence microscopy were
conﬁrmed by Q-RT-PCR of the erythroid-speciﬁc hbae1 and
myeloid-speciﬁc lcp1 transcripts in MO-targeted embryos
compared to uninjected controls in three or more independ-
ent experiments of n ¼ 5 embryos per experiment. A greater
than 2-fold reduction in both erythroid and myeloid gene
expression levels were seen for ﬁve of seven MOs analyzed
(see Table 1; Figures 3 and 4). Thus, the addition of Q-RT-
PCR to the screening process provides an independent
conﬁrmation and quantitation of the observed phenotypes,
thereby limiting the false-positive rate, while maintaining the
high-throughput nature of the screen. Additionally, the
observed reduction of both erythroid and myeloid gene
expression following knockdown of candidate genes is
consistent with their presumed roles in HSC fate decisions
prior to speciﬁcation of the common myeloid progenitor.
The validity of the Q-RT-PCR analysis was corroborated by
analysis of hbae1 and lcp1 transcript levels in gata1 MO-
targeted embryos, in which there was a virtually complete loss
of hbae1 expression and an almost 2-fold increase in myeloid-
speciﬁc lcp1 transcripts (Figure 4) consistent with the
published expression patterns for these genes following loss
of gata1 expression [37]. Analysis of vascular development by
Table 1. Genes Differentially Expressed between Human Rho
lo and Rho
hi Cell Populations That Have a Functional Role in Zebrafish
Hematopoietic Development
Human Gene Region Targeted Dose Hematopoietic Phenotype Expression Q-RT-PCR
C12orf2 59 UTR ATG combination 4.5 ng 90% with blood defect Rho
lo N/D
4.5 ng 95% with blood defect
3 ng 95% with blood defect >
CCR7 ATG 2 ng 90% with blood defect Rho
hi N/D
FLJ14917 ATG 7 ng 80% with blood defect Rho
lo Not confirmed
FOXM1 ATG 2 ng 70% with blood defect Rho
hi N/D
HDHD2 ATG 3 ng 75% with blood defect Rho
hi Not confirmed
HSPC039 59 UTR 3 ng 80% with blood defect Rho
hi N/D
IRAK3 59 UTR 2 ng 70% with blood defect Rho
lo Confirmed
SUZ12 ATG 3 ng 70% with blood defect Rho
hi N/D
MAFB ATG 4 ng 70% with blood defect Rho
hi N/D
MGC15875 ATG 4 ng 80% with blood defect Rho
lo Confirmed
MRPS6 59 UTR 4.5 ng 70% with blood defect Rho
hi N/D
PRKCH 59 UTR 4.5 ng 70% with blood defect Rho
lo Confirmed
SLC40A1 ATG 6 ng 90% with blood defect Rho
hi Confirmed
SNX5 ATG 5 ng 80% with blood defect Rho
hi N/D
SPARC ATG 7.5 ng 70% with blood defect Rho
hi N/D
SPRY1 ATG 59 UTR combination 3 ng 80% with blood defect Rho
lo Confirmed
4.5 ng 65% with blood defect
2n gþ 3 ng 70% with blood defect
ATG, start codon; N/D, not done.
DOI: 10.1371/journal.pbio.0030254.t001
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Functional Analysis of HSC Gene Expressioninjecting MOs into ﬂi1:enhanced green ﬂuorescent protein
(EGFP) Tg embryos, which express EGFP in endothelial cells,
demonstrated no major abnormalities in vascular morpho-
genesis or remodeling that precludes the circulation of the
remaining blood cells, indicating that the hematopoietic
defect is not secondary to a vascular phenotype (Figure 4;
Table S7).
The greater than 20% frequency of blood defects seen in
our screen compares very favorably with the 0.5%–1%
frequency of hematopoietic phenotypes seen by ethylnitro-
sourea mutagenesis screens that mutate genes in a near
random fashion [38] and the 4% of hematopoietic pheno-
types seen in a morpholino-based functional screen of the
zebraﬁsh secretome [39] (S. C. Ekker, unpublished data). The
high incidence of blood defects also demonstrates that the
candidate genes identiﬁed by comparing the transcriptome
of Rho
lo and Rho
hi cells represent genes with important roles
in HSC biology. We were unable to identify a candidate
ortholog in zebraﬁsh for 72/158 of the differentially expressed
human genes. This may be because currently only one quarter
of the zebraﬁsh genome is high-quality ﬁnished sequence.
Hence, some genes with important roles in hematopoiesis
may have been untested. However, from a sample of ten genes
that lacked a zebraﬁsh match, only one has a likely ortholog in
the Fugu or Medaka sequencing projects, and thus incom-
plete genome coverage provides only a partial explanation.
Alternative possibilities include a reduced level of primary
sequence conservation between functional orthologs that
would have been missed using our simple comparative
genomics criteria, or that a number of genes are not
conserved between ﬁsh and man, and thus might be less
important for the conserved processes of hematopoietic self-
renewal and differentiation. Therefore, the relatively high
incidence of blood defects in conserved genes may in part
reﬂect ‘‘evolutionary ﬁltering’’ in our screen. Consistent with
this hypothesis, all zebraﬁsh genes whose mutation resulted in
a visible embryonic phenotype identiﬁed using a retroviral
insertion strategy have a likely human ortholog [40].
Although the frequency of blood defects is high, the screen
is not as well suited for the identiﬁcation of knockdown
phenotypes that result in increased HSC proliferation and/or
differentiation. We and others have successfully shown that
dramatically increased hematopoietic development can be
modeled in zebraﬁsh, as is the case for knockdown of the
BMP-antagonist chd (chordin) and the corresponding dino
mutant [41,42]; however, more modest increases in hema-
topoietic cell production or skewing of lineage differentia-
tion may be undetectable. Although these caveats may lead to
underestimation of the true frequency of genes with a role in
early hematopoietic development and differentiation, the
screening procedure used has proven effective for extracting
functional information from a global gene expression
proﬁling dataset in a high-throughput manner.
Of note, viable knockout mice exist for 4/14 genes
identiﬁed in our functional screen (Sparc, Irak3, Ccr7, and
Prkch) [43–46]. One could argue that if a viable knockout
mouse exists, the gene of interest may not be important in
hematopoiesis. However, lack of an overt hematopoietic
phenotype does not preclude a role of a gene in HSC self-
renewal and differentiation, as this may only be detectable
under conditions where the hematopoietic system is stressed
or in transplantation experiments. For example, Hoxb4
 / 
mice develop normally and present with only subtle differ-
e n c e si ns p l e e na n dB Mc e l l u l arity [47]. However, the
proliferative response of HSC in vitro and in vivo is
decreased, consistent with the observation that overexpres-
sion of Hoxb4 supports expansion of competitive repopulat-
ing units and SCID-repopulating cells [4,5].
Characterization of Sprouty Family Members in Zebrafish
Hematopoiesis
To further verify the hematopoietic role of genes identiﬁed
by gene array, we performed a more extensive evaluation of
the zebraﬁsh targeted with an MO against spry4 (spry4
morphant or spry4
MO). Although human SPRY1 was differ-
Figure 3. Representative Hematopoietic Phenotypes Observed in MO-
Targeted Zebrafish
Fluorescence microscopic images of gata1:DsRed Tg zebrafish embryos
display the hematopoietic phenotypes observed for six MO-targeted
zebrafish embryos compared to an uninjected control. Phenotypes
shown are representative of greater than 70% of injected embryos at 48
hpf (greater than or equal to three experiments of n . 40 embryos).
Hematopoietic defects were quantified by Q-RT-PCR for the expression
of erythroid-specific hbae1 and myeloid-specific lcp1 transcripts in MO-
targeted embryos relative to uninjected clutchmate controls (greater
than or equal to three experiments of n ¼ 5 embryos; *p , 0.05).
DOI: 10.1371/journal.pbio.0030254.g003
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Functional Analysis of HSC Gene Expressionentially expressed, an MO against zebraﬁsh spry4 was used, as
it is expressed in the region of the lateral plate mesoderm, the
ﬁrst site of zebraﬁsh hematopoiesis [48], and it was the full-
length zebraﬁsh Sprouty gene with the greatest protein
homology to human SPRY1. Recently the partial sequence
of a potential zebraﬁsh spry1 ortholog was predicted by
Ensembl’s gene prediction software based on genomic
sequence information. However, the single exon that was
predicted does not contain an ATG start codon, or a
conserved splice donor or acceptor site, and the putative
zebraﬁsh spry1 sequence only partially covers the human
SPRY1 gene. Moreover, the genomic location of Ensembl’s
putative zebraﬁsh spry1 is currently not known, and therefore
it is not possible to use syntenic relationships to determine
the most likely zebraﬁsh ortholog for human SPRY1. At
present, there is not sufﬁcient sequence data available to
design gain- or loss-of-function experiments for the putative
zebraﬁsh spry1, thus precluding an analysis of hematopoietic
function in the zebraﬁsh model. Therefore, spry4 is currently
the best full-length, MO-targetable candidate ortholog for
human SPRY1, and based on our results, at the very least
zebraﬁsh spry4 and SPRY1 share a conserved function in
hematopoiesis.
To conﬁrm the speciﬁcity of MO targeting in the spry4
MO,
a second spry4 MO of independent sequence and a four-base
mismatched spry4 MO were injected into zebraﬁsh embryos.
Injection of the independent spry4 MOs induced a hema-
topoietic phenotype in more than 65% of injected embryos,
while the four-base mismatched MO did not induce any
phenotypic changes (Figure 4). Q-RT-PCR for hbae1 and lcp1
transcripts also did not show changes in expression in four-
base mismatched MO embryos. Furthermore, the two
independent spry4 MOs acted synergistically when coinjected
(Figure 4). In addition to the blood phenotype, a slight facial
outgrowth was seen at a low frequency. Also, a weak
dorsalization phenotype was seen at 2-fold higher MO doses
based on a decreased somite size.
To rule out the possibility that the hematopoietic defect
observed in the spry4
MO was secondary to a vascular defect,
we injected spry4 MO into ﬂi1:EGFP Tg zebraﬁsh. While the
resulting embryos exhibited minor defects in cardinal vein
remodeling and morphogenesis of intersegmental vessels in
Figure 4. spry4 Is Required for Normal Hematopoietic Development in Zebrafish Embryos
(A) The observed frequency of hematopoietic defects in gata1:DsRed Tg zebrafish embryos are indicated for two independent spry4-targeted MOs (MO1
and MO2; black bars), a four-base mismatched control MO (MM MO; no bar indicates a 0% frequency), a low-dose injection of MO1 and MO2 individually
and in combination (gray bars), and MO2 coinjected with a human SPRY1 DNA expression vector or a GFP control (white bars) (error bars ¼ standard
deviation of the mean, *p , 0.05, **p   0.01).
(B) Representative pictures of the phenotypes seen with spry4 MO1 at 48 h using fli1:EGFP/gata1:DsRed double Tg zebrafish embryos that have EGFP
þ
vascular endothelial cells and DsRed
þerythroid cells. The embryos display a more drastic reduction in DsRed
þblood cells with some blood pooling and
pericardial edema at higher MO doses (þþMO) without major vasculature defects. The gata1:DsRed and fli1:EGFP Tg images are representative of three
experiments of n . 40 embryos each.
(C) Q-RT-PCR analysis of hbae1 and lcp1 transcripts in spry4 MO1, control mismatch MO and a gata1 MO-injected zebrafish at 48 hpf (*p , 0.05).
(D) Injection of 30 pg of human SPRY1 DNA expression vector resulted in an expansion of DsRed
þ hematopoietic cells in the posterior ICM in greater
than 50% of successfully injected embryos at 32 hpf (three experiments of n ¼ 30), and a representative bright-field image is pictured with the
fluorescence micrograph overlaid (left). Q-RT-PCR analysis of hbae1 and lcp1 transcripts in SPRY1 overexpressing embryos relative to uninjected
clutchmate controls (three experiments of n ¼ 5 embryos) (right).
DOI: 10.1371/journal.pbio.0030254.g004
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Functional Analysis of HSC Gene Expressionthe posterior tail, there were no major defects in vascular
development (Figure 4). The integrity of the vascular network
in spry4
MO ﬁsh was further demonstrated by the unimpeded
circulation of the remaining DsRed
þ blood cells in ga-
ta1:DsRed Tg spry4
MO (data not shown).
Thisse et al. [35] have shown that overexpression of
zebraﬁsh spry4 mRNA leads to an expansion of the posterior
intermediate cell mass (ICM) [48]. We overexpressed human
SPRY1 in gata1:DsRed Tg zebraﬁsh embryos, and observed a
similar dose-dependent expansion of DsRed
þ blood cells in
the posterior ICM (Figure 4). Q-RT-PCR analysis of embryos
overexpressing SPRY1 revealed a 1.7- and 1.4-fold increase
hbae1 and lcp1 mRNA levels, respectively, conﬁrming the
observed expansion of blood cells in the ICM. Coinjection of
human SPRY1 cDNA with spry4 MOs ameliorated the spry4
MO
phenotype, yet another conﬁrmation of the speciﬁcity of MO
targeting (Figure 4). The similar hematopoietic phenotypes
observed following the overexpression of either human
SPRY1 or zebraﬁsh spry4 indicate that these genes encode
proteins with a similar functional potential in blood develop-
ment. In addition to the blood phenotype, the overexpression
often caused a reduction and/or curve in the posterior tail
(Figure 4) not seen in the overexpression of zebraﬁsh spry4
[48].
Characterization of hematopoietic gene expression in the
spry4
MO by whole-mount in situ hybridization revealed a
reduction in scl expression at four somites (8/15), and virtually
noscl(12/20)orgata1(18/25)expressionat20somites(Figure5),
consistent with a defect in mesodermal commitment to HSCs
and/or HSC proliferation and differentiation. The few hema-
topoieticcellsthatarepresentinthemorphantarehemoglobi-
nized based on o-dianisidine staining (data not shown). To
determine whether the hematopoietic defects observed in
spry4
MO were the result of a defect in mesoderm speciﬁcation
during development, we performed whole-mount in situ
hybridization for the vasculature-speciﬁc ﬂk1 and muscle-
speciﬁc myod transcripts. At 10 h postfertilization (hpf) there
was a slight defect in myod expression (5/10), while myod
expression at 26 hpf was comparable to wild type (21/21)
(Figure 5). This suggests that there were no major defects in
mesodermal commitment in the spry4 morphants. Consider-
ingthenearlyabsentexpressionoftheearlyhemangioblastand
HSC cell marker scl, these results may suggest that the defect
induced in the spry4
MO occurs prior to HSC speciﬁcation.
However, the normal expression pattern of other mesodermal
genes, such as ﬂk1 and myod at 26 hpf in the spry4
MO (Figure 5),
indicate that the hematopoietic phenotype is not merely a
consequence of defective speciﬁcation of mesoderm. Finally,
the hematopoietic gene cmyb, a presumed marker of deﬁnitive
HSC in zebraﬁsh [49], was absent at 38 hpf (10/12) (data not
shown), suggesting that the spry4
MO embryos are devoid of
deﬁnitive HSC.
In vertebrates, Sprouty family members act as antagonists
for ﬁbroblast growth factor (FGF), vascular endothelial
growth factor, and epidermal growth factor signaling, and
they may be involved in feedback regulation, as Sprouty gene
expression is induced by activation of these signaling path-
ways [50]. Sprouty genes antagonize receptor tyrosine kinase
signaling at the level of the Ras/Raf/mitogen-activated protein
kinase pathway; however, they also can serve as positive
regulators of these pathways in some cell types [50]. There-
fore, our current hypothesis is that SPRY1 may affect HSC by
modulating FGF-mediated, perhaps in combination with
other receptor tyrosine kinase-mediated, signaling. In fact,
three of the 14 genes that induce a hematopoietic defect in
the zebraﬁsh screen, SPRY1, MAFB and SPARC, are all
involved in FGF signaling [50–52], thus suggesting a role for
FGF in hematopoiesis. Studies are ongoing to conﬁrm a role
of SPRY1 in mammalian hematopoiesis, by testing the effect
of overexpression of SPRY1 on the repopulating ability of
human and murine HSCs. Similar deﬁnitive studies in
zebraﬁsh and subsequent conﬁrmation in mammalian HSC
models are underway for genes that were functionally
validated in our zebraﬁsh screen. We believe that the
sequential genetic screen in zebraﬁsh followed by conﬁrma-
tion in mammalian models as described here will establish a
hematopoietic function for genes identiﬁed by gene array
analysis in a high-throughput and efﬁcient manner.
Materials and Methods
Isolation of Rho
lo and Rho
hi cell populations from UCB and BM.
Human UCB from full-term delivered infants and BM from healthy
donors were obtained after informed consent in accordance with
guidelines approved by the University of Minnesota Committee on
the Use of Human Subjects in Research. Each biologically distinct
replicate was comprised of one to four donors for UCB and indi-
vidual donors for BM samples. CD34
þCD38
 CD33
 Rho
loc-kit
þ and
CD34
þCD38
 CD33
 Rho
hi fractions were selected by sequential Ficoll-
Hypaque separation, MACS column depletion, and ﬂuorescence-
activated cell sorting as previously described [17]. Postsort analysis
Figure 5. spry4 Is Required for Early Hematopoietic Development, but
Not Mesodermal Commitment, in Developing Zebrafish Embryos
(A) Expression of the early hematopoietic marker scl was reduced at the
four-somite stage (arrow) and virtually absent at the 20-somite stage in
spry4
MO embryos compared to uninjected controls.
(B) The more mature hematopoietic marker gata1 was also reduced in
spry4
MO compared to uninjected zebrafish embryos at 20 somites.
(C and D) In contrast to hematopoietic genes, the mesodermal-specific
flk1 (vasculature) transcripts were expressed at similar levels to
uninjected controls at 26 hpf, and myod (muscle) had a slight defect
(arrowhead) at 10 hpf, while expression was similar to controls at 26 hpf.
All images are representative of greater than or equal to two
experiments of n   8 embryos.
DOI: 10.1371/journal.pbio.0030254.g005
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Functional Analysis of HSC Gene Expressiondemonstrated that sorted populations contained fewer than 1%–2%
contaminating cells from the opposing population (see Figure 1).
Determination of ML–IC frequencies. ML–IC frequencies for UCB
samples (n¼3) were determined as previously described [17]. An ML–
IC was deﬁned as a single cell that gave rise to at least one LTC–IC
and one NK–IC. Results are presented as ML–IC frequency 6
standard deviation of the mean.
Processing of RNA samples and oligonucleotide microarray
analysis. Total cellular RNA was isolated from UCB (n ¼ 5) and BM
(n ¼ 4) Rho
lo and Rho
hi cells using the PicoPure RNA Isolation Kit
(Arcturus, Mountain View, California, United States) per the
manufacturer’s instructions. Seven to 10,000 Rho
lo and Rho
hi cells
were sorted directly into 100 ll extraction buffer (XB) provided with
the PicoPure RNA Isolation Kit prior to RNA isolation. Labeled cRNA
was generated by one round of IVT-based, linear ampliﬁcation using
the RiboAmp OA RNA Ampliﬁcation Kit (Arcturus) followed by
labeling with the Enzo Bioarray HighYield RNA Transcript Labeling
Kit (Enzo Life Sciences, Farmingdale, New York, United States)
according to manufacturer’s instructions. Samples were hybridized to
Affymetrix HG-U133 A and B chips (Affymetrix Inc., Santa Clara,
California, United States) were washed, and scanned at the University
of Minnesota Affymetrix Microarray Core Facility as described in the
Affymetrix GeneChip Expression Analysis Technical Manual.
Oligonucleotide microarray data analysis. Affymetrix HG-U133
GeneChips were processed using GeneData Reﬁner software (Gene-
Data,SanFrancisco,California, UnitedStates)to assessoverallquality.
Feature intensities for each chip were condensed into a single
intensity value per gene using the Affymetrix Statistical Algorithm
(MAS 5.0) with s ¼ 0.015, a1 ¼ 0.04, a2 ¼ 0.06, and a scaling factor of
500. Expression data was analyzed using GeneData’s Expressionist and
Microsoft Excel (Microsoft, Redmond, Washington, United States).
Differential gene expression for comparison of Rho
lo versus Rho
hi
cells was deﬁned by using a paired Student’s t-test with a threshold of
p , 0.05, and a paired fold change was used to rank gene lists. Differ-
entially expressed genes were classiﬁed according to their respective
gene pathways and gene ontologies when available by using the Web-
based Affymetrix NetAffx analysis tool (http://www.affymetrix.com)
and the National Institutes of Allergy and Infectious Disease Database
for Annotation, Visualization and Integrated Discovery analysis tool
(DAVID) (http://apps1.niaid.nih.gov/david).
Microarray Q-RT-PCR conﬁrmation. Labeled cRNA was reverse
transcribed to generate cDNA using SuperScript II Reverse Tran-
scriptase (Invitrogen, Carlsbad, California, United States) according
to manufacturer’s instructions. Q-RT-PCR was performed using the
ABI Prism 7000 Sequence Detection System (Applied Biosystems,
Foster City, California, United States). Brieﬂy, 3 ng of cDNA was
ampliﬁed by 40 cycles of a two-step PCR reaction (95 8C for 15 s
denaturation and 60 8C for 1 min. annealing/elongation) containing
100 nM gene-speciﬁc primers (Table S8) and the SYBR Green PCR
Master Mix (Applied Biosystems). Gene expression was normalized
using human ACTB (also b-actin) expression levels. Results are
presented as percent expression relative to uninjected clutchmate
control embryos 6 standard deviation of the mean.
High-throughput loss-of-function genetic screen in zebraﬁsh. The
likelyzebraﬁshorthologsofdifferentiallyexpressedhumangeneswere
identiﬁed using Ensembl’s gene homology prediction program (http://
www.ensembl.org, build Zv3) in combination with comparison of the
human protein sequence to the Institute for Genomic Research
zebraﬁsh EST database (http://www.tigr.org, release 13–15). The
criteria for a likely ortholog was   40% amino acid identity over the
entire length of the protein or   50% if the ﬁsh protein sequence was
only partial. MO (Gene Tools, Philomath, Oregon, United States)
sequences were designed complimentary to the region of translational
initiation of the zebraﬁsh orthologs in order to inhibit protein
translation (Table S6) and injected into one- to two-cell zebraﬁsh
embryos as previously described [36]. MOs were injected at 1.5, 3, 4.5,
and 6 ng into 50–70 embryos derived from mating Tg zebraﬁsh
containing a ﬂuorescent DsRed reporter cassette driven by the gata1
promoter (gata1:DsRed Tg) or a ﬂuorescent EGFP reporter cassette
driven by the ﬂi1 promoter (ﬂi1:EGFP Tg). MO-targeted (morphant)
zebraﬁsh were evaluated for defects in hematopoietic and vascular
development compared to uninjected controls from the same embryo
clutch at 30 and 48 hpf, using ﬂuorescence microscopy for visual-
ization of DsRed
þ blood cells and EGFP
þ vasculature.
Whole zebraﬁsh Q-RT-PCR conﬁrmation. Total RNA was isolated
from ﬁve MO-injected zebraﬁsh embryos at 48 hpf with hemato-
poietic defects, determined based on gata1:DsRed
þhematopoietic cell
production, or ﬁve uninjected clutchmate controls using the RNeasy
Mini Kit (Qiagen, Valencia, California, United States) according to
the manufacturer’s instructions. Total RNA was incubated with
DNaseI (Invitrogen) to digest contaminating genomic DNA, and
reverse transcribed to generate cDNA using SuperScript II Reverse
Transcriptase (Invitrogen) according to the manufacturer’s protocol.
Q-RT-PCR was performed using the ABI Prism 7000 Sequence
Detection System (Applied Biosystems). Brieﬂy, 1/20 of the total
cDNA from ﬁve zebraﬁsh embryos was ampliﬁed by 40 cycles of a
two-step PCR reaction (95 8C for 15 s denaturation and 60 8C for 1
min. annealing/elongation) containing 100 nM gene-speciﬁc primers
(Table S8) and the SYBR Green PCR Master Mix (Applied
Biosystems). Gene expression was normalized using a zebraﬁsh gapd
expression level. Results are presented as percentage expression
relative to uninjected clutchmate control embryos 6 standard
deviation of the mean.
Whole-mount in situ hybridization. Thescl,myod,ﬂk1,gata1,andcmyb
riboprobes were generated and whole-mount in situ hybridization of
zebraﬁsh embryos was conducted as previously described [41].
Overexpression of human and zebraﬁsh Sprouty gene family
members. The XhoI and KpnI fragment of the SPRY1 open reading
frame (ORF) (Open Biosystems, Huntsville, Alabama, United States)
was cloned into pENTR1A (Invitrogen) and subsequently transferred
into a modiﬁed pFRM2.1 zebraﬁsh expression vector using the
Gateway cloning system (Invitrogen) to create the pFRM2.1–SPRY1
vector. pFRM2.1–SPRY1 was coinjected with pFRM2.1–EGFP at a 5:1
ratio into the yolk/cell interface of one-cell gata1:DsRed Tg zebraﬁsh
embryos as described for MO injections. Defects in hematopoietic
development of EGFP
þ embryos were analyzed by comparison to
embryos from the same clutch injected with pFRM2.1–EGFP alone,
using ﬂuorescence microscopy to visualize DsRed
þ blood cells.
Supporting Information
Figure S1. Frequency of ML–IC in UCB Rho
lo and Rho
hi Cell
Populations
ML–ICs are highly enriched in Rho
lo (white bar) compared to Rho
hi
(black bar) cells from UCB (n ¼ 3, *p , 0.05).
Found at DOI: 10.1371/journal.pbio.0030254.sg001 (3.6 MB TIF).
Figure S2. Conﬁrmation of Differential Gene Expression Using Q-
RT-PCR
The Rho
lo to Rho
hi fold change for DLK1, ABCB1, BMP6, HELLS,
CDC25A, MAFB, and S100A8 was determined using Affymetrix
GeneChip analysis (gray bars) and Q-RT-PCR (black bars) to conﬁrm
the ﬁdelity of the microarray results for (A) adult BM (n   2) and (B)
UCB (n   3).
Found at DOI: 10.1371/journal.pbio.0030254.sg002 (7.2 MB TIF).
Figure S3. Gene Ontology Classiﬁcations of Conserved Differentially
Expressed Genes
Percentages of Gene Ontology classiﬁcations of the genes differ-
entially expressed between Rho
lo and Rho
hi cells from both UCB
and adult BM (p , 0.05 and fold change . 1.5 in either UCB or
BM).
Found at DOI: 10.1371/journal.pbio.0030254.sg003 (2.7 MB TIF).
Table S1. Probe Sets Differentially Expressed between UCB-Derived
Rho
lo and Rho
hi Cells (p , 0.05)
Found at DOI: 10.1371/journal.pbio.0030254.st001 (437 KB XLS).
Table S2. Probe Sets Differentially Expressed between Adult BM-
Derived Rho
lo and Rho
hi Cells (p , 0.05)
Found at DOI: 10.1371/journal.pbio.0030254.st002 (738 KB XLS).
Table S3. Conserved Probe Sets Differentially Expressed between
Rho
lo and Rho
hi Cells from Both UCB and Adult BM (p , 0.05 and FC
. 1.5 in Either UCB or BM)
Found at DOI: 10.1371/journal.pbio.0030254.st003 (75 KB XLS).
Table S4. Fold Changes, p-Values, and Average Expression Levels for
Genes with Well-Established Roles in HSC Proliferation and Differ-
entiation
Found at DOI: 10.1371/journal.pbio.0030254.st004 (17 KB XLS).
Table S5. Comparison of Conserved Rho
lo-Enriched Genes with
Ramalho-Santos et al. [13] Dataset
Found at DOI: 10.1371/journal.pbio.0030254.st005 (22 KB XLS).
Table S6. Morpholino Sequences for Targeted Genes
Found at DOI: 10.1371/journal.pbio.0030254.st006 (20 KB XLS).
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Functional Analysis of HSC Gene ExpressionTable S7. Complete Phenotypic Descriptions for the 14 Zebraﬁsh
Morphants with Conﬁrmed Blood Defects
Found at DOI: 10.1371/journal.pbio.0030254.st007 (19 KB XLS).
Table S8. Q-RT-PCR Primer Sequences
Found at DOI: 10.1371/journal.pbio.0030254.st008 (16 KB XLS).
Accession Numbers
The National Center for Biotechnology Information (http://
www.ncbi.nlm.nih.gov/) Entrez Gene accession numbers for the
following genes are: ABCB1 (5243), ARMCX2 (9823), BMP4 (652),
C12orf2 (11228), CCR7 (1236), Ccr7 (12775), CDKN1A (1026), chd
(30161), cmyb (30519), CRYGD (1421), EVI1 (2122), EZH2 (2146),
FLJ14917 (84947), ﬂk1 (also known as kdr) (58106), FOXM1 (2305),
gata1 (30481), GATA2 (2624), gata2 (30480), hbae1 (30597), HDHD2
(84064), HELLS (3070), HLF (3131), HMGA2 (8091), Hoxb4 (15412),
HOXB4 (3214), HSPC039 (51124), IRAK3 (11213), Irak3 (73914),
KIAA1102 (22998), KLF5 (688), lcp1 (30583), LEF1 (51176), LMO2
(4005), lmo2 (30332), MAFB (9935), MGC15875 (85007), MRPS6
(64968), myod (30513), NOTCH2 (4853), PIM1 (5292), PRKCH (5583),
Prkch (18755), RBPMS (11030), scl (also known as tal1) (30766), SHH
(6469), SLC40A1 (30061), SLCO3A1 (28232), SNX5 (27131), SPARC
(6678), Sparc (20692), spry4 (114437), SPRY1 (10252), SSBP2 (23635),
SUZ12 (23512), ZFHX1B (9839), ZNF165 (7718), and ZNF331 (55422).
The microarray data in this manuscript have been deposited in the
GEO database (http://www.ncbi.nlm.nih.gov/geo/), and have been
assigned the accession number GSE2666.
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